Revolution Medicines, Inc. (RVMD) fell 17.11 percent, or $20.14, to $97.54 in active trading, despite no company-specific news driving the move.
The sharp decline appears to reflect broad selling pressure following recent gains in the stock.
Shares opened significantly lower at $93.46, compared with a previous close of $117.68. The stock traded in a wide range between $92.50 and $99.51 during the session on the Nasdaq. Trading volume surged to about 7.79 million shares, well above the average volume of roughly 3.30 million.
Revolution Medicines has traded between $29.17 and $124.49 over the past 52 weeks, highlighting elevated volatility as investors reassess valuations across the biotech sector.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.